Hair Loss Treatment MarketSize and Trends

Global Hair Loss Treatment Market is estimated to be valued at US$ 4.24 Billion in 2023, and is expected to exhibit a CAGR of 6.2% during the forecast period (2023-2030). Increasing incidence of alopecia and other diseases that leads to hair loss, and increasing research and development activities by key market players are expected to drive the market growth.

Market Trends

Increasing incidence of alopecia and other disease that leads to hair loss: Increasing prevalence of diseases such as telogen effluvium, androgenetic alopecia, alopecia areata, and others is expected to boost demand for hair loss treatment, thus, propelling the market growth over the forecast period. For instance, on July 23, 2023, according to an article published by the U.S. Department of Health and Human Services, more than 50 Mn men and 30 Mn women are estimated to be affected by androgenetic alopecia in U.S. each year
Increasing research and development activities by key market players: Key market players are focusing on adoption of research and development activities for treatment of hair loss diseases such as alopecia areata, and this is expected to drive the market growth over the forecast period. For instance, Concert Pharmaceuticals, a subsidiary of Sun Pharmaceutical Industries Pvt. Ltd., a India-based global pharmaceutical company, has its drug candidate CTP-543 is in phase-III of clinical trial. The CTP-543 is been tested for a treatment solution for alopecia areata.

Hair Loss Treatment Market Report Snapshots